↓ Skip to main content

The Effects of Bilirubin and Lumirubin on Metabolic and Oxidative Stress Markers

Overview of attention for article published in Frontiers in Pharmacology, March 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
2 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Effects of Bilirubin and Lumirubin on Metabolic and Oxidative Stress Markers
Published in
Frontiers in Pharmacology, March 2021
DOI 10.3389/fphar.2021.567001
Pubmed ID
Authors

Aleš Dvořák, Kateřina Pospíšilová, Kateřina Žížalová, Nikola Capková, Lucie Muchová, Marek Vecka, Nikola Vrzáčková, Jana Křížová, Jaroslav Zelenka, Libor Vítek

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 18%
Student > Master 2 18%
Student > Bachelor 1 9%
Unspecified 1 9%
Unknown 5 45%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 18%
Environmental Science 1 9%
Unspecified 1 9%
Nursing and Health Professions 1 9%
Chemistry 1 9%
Other 0 0%
Unknown 5 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 March 2024.
All research outputs
#6,448,749
of 23,301,510 outputs
Outputs from Frontiers in Pharmacology
#2,683
of 16,738 outputs
Outputs of similar age
#142,266
of 420,392 outputs
Outputs of similar age from Frontiers in Pharmacology
#111
of 644 outputs
Altmetric has tracked 23,301,510 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 16,738 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 420,392 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 644 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.